Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial.
J Clin Pharmacol
; 63(12): 1387-1397, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37562063
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Infections
/
Gram-Negative Bacterial Infections
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
J Clin Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido